The Israel Cancer Research Fund (ICRF) is proud to be an
official charity partner of the 2022 TCS New York City Marathon.
Together, we are fundraising to support groundbreaking cancer research conducted
by the best and brightest scientists at leading institutions throughout Israel,
with a team goal of $36,000. Our goal is to end the suffering caused by
invests in the most promising Israeli scientists to advance ways to prevent,
diagnose and treat cancer. To date, ICRF has funded over 2,700
more than $87.5 million to scientists
at leading Israeli institutions. In the current funding year, ICRF is
supporting 83 promising cancer research projects, making us the largest
nongovernmental funder of cancer research in Israel.